共 50 条
- [3] Pharmacokinetics, pharmacodynamics and tolerability of single dose of recombinant glucagon-like peptide-1 receptor agonist in healthy Chinese subjects INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (05): : 8018 - 8024
- [4] Initiating a Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes Mellitus JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2012, 112 (01): : S16 - S21
- [8] Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin DIABETES OBESITY & METABOLISM, 2014, 16 (08): : 739 - 747
- [10] Improving Glucagon-like Peptide-1 Dynamics in Patients With Type 2 Diabetes Mellitus JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2012, 112 (01): : S2 - S6